• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同步放化疗后手术治疗的食管癌患者术后肺部并发症风险的剂量-体积建模

Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

作者信息

Tucker Susan L, Liu H Helen, Wang Shulian, Wei Xiong, Liao Zhongxing, Komaki Ritsuko, Cox James D, Mohan Radhe

机构信息

Department of Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):754-61. doi: 10.1016/j.ijrobp.2006.06.002. Epub 2006 Sep 11.

DOI:10.1016/j.ijrobp.2006.06.002
PMID:16965865
Abstract

PURPOSE

The aim of this study was to investigate the effect of radiation dose distribution in the lung on the risk of postoperative pulmonary complications among esophageal cancer patients.

METHODS AND MATERIALS

We analyzed data from 110 patients with esophageal cancer treated with concurrent chemoradiotherapy followed by surgery at our institution from 1998 to 2003. The endpoint for analysis was postsurgical pneumonia or acute respiratory distress syndrome. Dose-volume histograms (DVHs) and dose-mass histograms (DMHs) for the whole lung were used to fit normal-tissue complication probability (NTCP) models, and the quality of fits were compared using bootstrap analysis.

RESULTS

Normal-tissue complication probability modeling identified that the risk of postoperative pulmonary complications was most significantly associated with small absolute volumes of lung spared from doses > or = 5 Gy (VS5), that is, exposed to doses < 5 Gy. However, bootstrap analysis found no significant difference between the quality of this model and fits based on other dosimetric parameters, including mean lung dose, effective dose, and relative volume of lung receiving > or = 5 Gy, probably because of correlations among these factors. The choice of DVH vs. DMH or the use of fractionation correction did not significantly affect the results of the NTCP modeling. The parameter values estimated for the Lyman NTCP model were as follows (with 95% confidence intervals in parentheses): n = 1.85 (0.04, infinity), m = 0.55 (0.22, 1.02), and D50 = 17.5 Gy (9.4 Gy, 102 Gy).

CONCLUSIONS

In this cohort of esophageal cancer patients, several dosimetric parameters including mean lung dose, effective dose, and absolute volume of lung receiving < 5 Gy provided similar descriptions of the risk of postoperative pulmonary complications as a function of the radiation dose distribution in the lung.

摘要

目的

本研究旨在探讨肺癌放疗剂量分布对食管癌患者术后肺部并发症风险的影响。

方法与材料

我们分析了1998年至2003年在我院接受同步放化疗后行手术治疗的110例食管癌患者的数据。分析的终点是术后肺炎或急性呼吸窘迫综合征。使用全肺的剂量体积直方图(DVH)和剂量质量直方图(DMH)来拟合正常组织并发症概率(NTCP)模型,并通过自助分析比较拟合质量。

结果

正常组织并发症概率模型确定,术后肺部并发症的风险与接受≥5 Gy剂量的肺的小绝对体积(VS5)最显著相关,即接受<5 Gy剂量的肺。然而,自助分析发现该模型与基于其他剂量学参数(包括平均肺剂量、有效剂量和接受≥5 Gy剂量的肺的相对体积)的拟合质量之间没有显著差异,可能是因为这些因素之间存在相关性。DVH与DMH的选择或分割校正的使用对NTCP建模结果没有显著影响。Lyman NTCP模型估计的参数值如下(括号内为95%置信区间):n = 1.85(0.04,无穷大),m = 0.55(0.22,1.02),D50 = 17.5 Gy(9.4 Gy,102 Gy)。

结论

在这组食管癌患者中,包括平均肺剂量、有效剂量和接受<5 Gy剂量的肺的绝对体积在内的几个剂量学参数,对术后肺部并发症风险的描述与肺内放疗剂量分布的函数关系相似。

相似文献

1
Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.同步放化疗后手术治疗的食管癌患者术后肺部并发症风险的剂量-体积建模
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):754-61. doi: 10.1016/j.ijrobp.2006.06.002. Epub 2006 Sep 11.
2
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.对接受同步放化疗后手术治疗的食管癌患者术后肺部并发症相关临床和剂量学因素的调查。
Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):692-9. doi: 10.1016/j.ijrobp.2005.08.002. Epub 2005 Oct 19.
3
Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.非小细胞肺癌适形放疗患者急性食管炎的正常组织并发症概率建模
Radiother Oncol. 2005 Nov;77(2):176-81. doi: 10.1016/j.radonc.2005.10.001. Epub 2005 Oct 26.
4
Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models.乳腺癌放疗后的早期临床和放射学肺部并发症:正常组织并发症概率与四种不同模型的拟合情况
Radiother Oncol. 2007 Mar;82(3):308-16. doi: 10.1016/j.radonc.2006.12.001. Epub 2007 Jan 16.
5
Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.直肠剂量-壁直方图与剂量-体积直方图在模拟放疗后晚期直肠出血发生率方面的比较。
Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1589-601. doi: 10.1016/j.ijrobp.2004.07.712.
6
Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy.三维适形放疗治疗肺癌患者急性食管毒性的剂量-体积参数
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):995-1002. doi: 10.1016/j.ijrobp.2004.12.025.
7
Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.非小细胞肺癌患者高剂量适形放疗后的急性食管毒性
Radiother Oncol. 2005 May;75(2):157-64. doi: 10.1016/j.radonc.2005.03.021.
8
Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).使用不同的正常组织并发症概率模型拟合晚期直肠出血数据:一项意大利多中心研究(AIROPROS0101)的结果
Radiother Oncol. 2004 Oct;73(1):21-32. doi: 10.1016/j.radonc.2004.08.013.
9
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy.接受调强放疗和同步化疗后行胸段食管癌切除术的患者中临床和剂量学因素与术后肺部并发症的相关性
Ann Surg Oncol. 2009 Jun;16(6):1669-77. doi: 10.1245/s10434-009-0401-0. Epub 2009 Mar 7.
10
Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.接受根治性放化疗的不可切除食管癌患者发生心包积液的危险因素。
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):707-14. doi: 10.1016/j.ijrobp.2007.10.056. Epub 2008 Jan 11.

引用本文的文献

1
Potential of automated online adaptive proton therapy to reduce margins for oesophageal cancer.自动化在线自适应质子治疗在减少食管癌边界方面的潜力。
Phys Imaging Radiat Oncol. 2025 Jan 31;33:100712. doi: 10.1016/j.phro.2025.100712. eCollection 2025 Jan.
2
A Prospective Pilot Study of Pencil Beam Scanning Proton Radiation Therapy as a Component of Trimodality Therapy for Esophageal Cancer.一项关于笔形束扫描质子放射治疗作为食管癌三联疗法组成部分的前瞻性初步研究。
Adv Radiat Oncol. 2024 Jun 6;9(8):101547. doi: 10.1016/j.adro.2024.101547. eCollection 2024 Aug.
3
Role of shrinkage in esophageal-gastric junction cancer.
收缩在食管胃交界癌中的作用。
Clin Case Rep. 2023 Jun 12;11(6):e6982. doi: 10.1002/ccr3.6982. eCollection 2023 Jun.
4
Assessment of a diaphragm override strategy for robustly optimized proton therapy planning for esophageal cancer patients.评估一种膈肌覆盖策略,以实现食管癌患者质子治疗计划的稳健优化。
Med Phys. 2021 Oct;48(10):5674-5683. doi: 10.1002/mp.15114. Epub 2021 Aug 5.
5
A Primer on Dose-Response Data Modeling in Radiation Therapy.辐射治疗中剂量反应数据建模概论。
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):11-20. doi: 10.1016/j.ijrobp.2020.11.020. Epub 2020 Dec 23.
6
The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment.肿瘤标志物在食管癌治疗中用于量化治疗期间的摆位误差和基线偏移。
Clin Transl Radiat Oncol. 2020 Nov 5;26:8-14. doi: 10.1016/j.ctro.2020.11.001. eCollection 2021 Jan.
7
Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.容积调强弧形放疗与调强质子放疗在局部晚期食管癌新辅助放疗中的应用比较
Radiat Oncol. 2020 May 24;15(1):120. doi: 10.1186/s13014-020-01570-y.
8
Revisiting the role of dose escalation in esophageal cancer in the era of modern radiation delivery.重新审视现代放疗时代剂量递增在食管癌治疗中的作用。
J Thorac Dis. 2020 Apr;12(4):1624-1627. doi: 10.21037/jtd.2020.02.38.
9
Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation.肝照射后 Child-Pugh 评分和白蛋白-胆红素等级增加的剂量分析和正常组织并发症概率建模。
Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):986-995. doi: 10.1016/j.ijrobp.2020.04.027. Epub 2020 Apr 27.
10
The emerging role of proton therapy for esophagus cancer.质子治疗在食管癌治疗中的新作用。
J Gastrointest Oncol. 2020 Feb;11(1):144-156. doi: 10.21037/jgo.2019.11.04.